Healthcare Costs Among Patients with Psoriasis Treated with Ixekizumab Versus Secukinumab in Real-World Settings Over 24 Months.

Blauvelt, Andrew; Shi, Nianwen; Burge, Russel; Atiya, Bilal; Zhu, Baojin; Somani, Najwa; Ridenour, Terri; Lew, Carolyn R; Zimmerman, Nicole M; Murage, Mwangi J

Blauvelt, Andrew; Shi, Nianwen; Burge, Russel; Atiya, Bilal; Zhu, Baojin; Somani, Najwa; Ridenour, Terri; Lew, Carolyn R; Zimmerman, Nicole M; Murage, Mwangi J.

Afiliación

Blauvelt A; Oregon Medical Research Center, Portland, OR, USA.
Shi N; IBM Watson Health, Cambridge, MA, USA.
Burge R; Value, Evidence, and Outcomes (VEO), Eli Lilly and Company, LCT-South Building 171-2, Drop Code 5221, 1555 Harding St., Indianapolis, IN, 46221, USA.
Atiya B; University of Cincinnati, Cincinnati, OH, USA.
Zhu B; Value, Evidence, and Outcomes (VEO), Eli Lilly and Company, LCT-South Building 171-2, Drop Code 5221, 1555 Harding St., Indianapolis, IN, 46221, USA.
Somani N; Value, Evidence, and Outcomes (VEO), Eli Lilly and Company, LCT-South Building 171-2, Drop Code 5221, 1555 Harding St., Indianapolis, IN, 46221, USA.
Ridenour T; Value, Evidence, and Outcomes (VEO), Eli Lilly and Company, LCT-South Building 171-2, Drop Code 5221, 1555 Harding St., Indianapolis, IN, 46221, USA.
Lew CR; Value, Evidence, and Outcomes (VEO), Eli Lilly and Company, LCT-South Building 171-2, Drop Code 5221, 1555 Harding St., Indianapolis, IN, 46221, USA.
Zimmerman NM; IBM Watson Health, Cambridge, MA, USA.
Murage MJ; IBM Watson Health, Cambridge, MA, USA.

Pharmacoecon Open ; 6(6): 871-880, 2022 Nov.

Article en En | MEDLINE | ID: mdl-36155891

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Pharmacoecon Open Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google